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In kidney disease renal proximal tubular epithelial cells
(RPTEC) actively contribute to the progression of
tubulointerstitial fibrosis by mediating both an inflammatory
response and via epithelial-to-mesenchymal transition. Using
laser capture microdissection we specifically isolated RPTEC
from cryosections of the healthy parts of kidneys removed
owing to renal cell carcinoma and from kidney biopsies from
patients with proteinuric nephropathies. RNA was extracted
and hybridized to complementary DNA microarrays after
linear RNA amplification. Statistical analysis identified 168
unique genes with known gene ontology association, which
separated patients from controls. Besides distinct alterations
in signal-transduction pathways (e.g. Wnt signalling),
functional annotation revealed a significant upregulation of
genes involved in cell proliferation and cell cycle control (like
insulin-like growth factor 1 or cell division cycle 34), cell
differentiation (e.g. bone morphogenetic protein 7), immune
response, intracellular transport and metabolism in RPTEC
from patients. On the contrary we found differential
expression of a number of genes responsible for cell
adhesion (like BH-protocadherin) with a marked
downregulation of most of these transcripts. In summary, our
results obtained from RPTEC revealed a differential
regulation of genes, which are likely to be involved in either
pro-fibrotic or tubulo-protective mechanisms in proteinuric
patients at an early stage of kidney disease.
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Usually end-stage renal failure is the terminal phase of a
chronic disease and epidemiological studies indicate that up
to 11% of the general population exhibit some abnormality
of kidney function.1,2 Proteinuria has been accepted as a
typical marker of kidney damage but urinary protein
excretion has also been shown to actively contribute to the
progression of the disease by affecting renal proximal tubular
epithelial cell (RPTEC) function, and by promoting tubular
atrophy and interstitial fibrosis. Increased glomerular filtra-
tion has been described for many potentially tubulotoxic
proteins: In vitro albumin stimulates the expression of
monocyte chemoattractant protein-1 and interleukin-8 via
reactive oxygen species generation3,4 and in an animal model
of proteinuric renal disease blockade of monocyte chemoat-
tractant protein-1 expression attenuates tubulointerstitial
injury.5 When incubated with delipidated albumin, immu-
noglobulin G, or transferrin, RPTEC show increased
expression of endothelin-1, which represents a strong
chemoattractant for monocytes and macrophages.6 Similarly
the production of regulated upon activation normal T-cell
expressed and secreted and transforming growth factor-beta1
(TGF-b1)7,8 is increased and the expression of insulin-like
growth factor-1 (IGF-1) is altered.9 Thus, in RPTEC
proteinuria induces a gene expression profile, which favors
the recruitment of macrophages and promotes tubular
atrophy and interstitial fibrosis. In the last decade the
epithelial-to-mesenchymal transition (EMT) of tubule cells
has been identified as another significant mechanism, which
contributes to progression of tubulointerstitial fibrosis.
Factors with the ability to induce EMT include TGF-b1,
epidermal growth factor, basic fibroblast growth factor, and
interleukin-1.10 Just recently bone morphogenetic protein 7
(BMP-7) has been found to counteract TGF-b1 induced EMT
and to reverse chronic renal injury.11 However, it is not clear
if human RPTEC display changes of global gene expression at
early stages of proteinuric kidney disease when excretory
renal function is close to normal. The objective of this study
was, therefore, to identify genes and pathways specifically in
human RPTEC using complementary (cDNA) microarrays.
Normal renal tissue sections obtained from the unaffected
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part of organs removed because of renal cell carcinoma
served as controls.
RESULTS
Microarray quality
All microarray experiments were processed as technical
duplicates. Average Pearson’s correlation coefficient between
two replicate arrays was 0.95. We used the sector analysis of
variance tool from the Stanford Microarray Database to
check every single microarray for hybridization artefacts.12
The mean r2 sector analysis of variance value of 0.01970.015
indicated no evidence of a hybridization bias.
Genes, biological processes, and pathways expressed differ-
entially between proteinuric patients and control subjects
A supervised cluster analysis using significance analysis of
microarrays and a t-test with max t-correction for multiple
testing in order to identify subsets of genes differentially
regulated between proteinuric patients and healthy controls
reported 261 (significance analysis of microarrays) and 58
(t-test) differentially regulated cDNA clones. A combination
of both methods resulted in 275 cDNA clones representing
230 unique genes, 168 of which could be assigned to gene
ontology terms (Table 1); the remaining 62 sequences were
hypothetical proteins, open-reading frames, and expressed
sequence tags (Table S1). The ratio of up- and downregulated
genes was balanced with 83 of the 168 genes being
significantly up- and 85 genes being downregulated in
proteinuric patients. The complete list of enriched
PANTHER ontology categories (i.e. biological processes
which are found to show a higher or a lower prevalence in
patients than in a reference gene list) is shown in Tables S2
and S3.
Apoptosis. We found a decreased expression of the BCL-
2-interacting killer and the human T-cell leukemia virus type
1 binding protein 1. Although BCL-2-interacting killer is
known to facilitate programmed cell death via interaction
with survival-promoting proteins (e.g. bcl2), T-cell leukemia
virus type 1 binding protein 1 exerts antiapoptotic proper-
ties. TIA1 cytotoxic granule-associated RNA binding protein
was also downregulated, however its exact role in apoptosis is
unclear.
Cell adhesion and differentiation. Significant alterations in
the expression of the cell adhesion genes thrombospondin-3
(TSP-3, THBS3), a disintegrin and metalloproteinase domain
22, neural cell adhesion molecule 1, contactin 3, BH-
protocadherin7, CD226 antigen, fibronectin 1, collagen type
16 alpha 1 and cysteine-rich angiogenic inducer 61 suggest
proteinuria induced decrease in cell-to-cell and cell-to-matrix
interactions of RPTEC. TSP-3, a recently discovered member
of the TSP family with a functional role in cell adhesion,13
shares a sequence similarity in the COOH terminus with
TSP-1. The balance between the latter and fibronectin, whose
expression was also changed, has recently been proposed as
an early indicator of aberrant proximal tubule and collecting
duct differentiation.14
We did not find significant differential expression of TGF-
b1 – the most prominent inducer of EMT. However, we
observed a downregulation of V-ski sarcoma viral oncogene
homolog (SKI). Reduced expression of ski has been described
in fibrotic kidney after obstructive injury, and it is has been
shown that the loss of ski expression in vitro might amplify
TGF-b1 signalling.15 On the other hand the expression of
BMP-7 was strongly and consistently elevated in proteinuric
subjects.
Interestingly we also found a reduced expression of
cysteine-rich angiogenic inducer 61. Cysteine-rich angiogenic
inducer 61 is a growth factor-inducible protein responsible
for promotion of cell proliferation as well as of cell adhesion
through the interaction with integrins. The marked down-
regulation of this transcript is compatible with a decreased
cell adhesion but also links proteinuria to an inhibition
of fibroblast apoptosis, as very recently suggested by
Todorovicc et al.16
Cell proliferation and cell cycle control. Increased expres-
sion of IGF-1 as well as of cell division cycle 34, annexin 13,
ras-related oncogene and mitogen-activated protein (MAP)/
microtubule affinity-regulating kinase 3 – which is a CDC25C
associated protein promoting the cell cycle at G2/M
transition – points to a enhanced proliferation of RPTEC.
This hypothesis is further underlined by decreased expression
of three phosphatases, which negatively regulate cell growth,
namely the magnesium-dependent protein phosphatases 1D
and 1B and the phosphatidic acid phosphatase type 2A.
These findings underscore recent in vitro results showing that
albumin – at least at low concentrations and with a high fatty
acid content – stimulates cell turn-over by stimulating
proliferation of tubule cells.17–19
Immune response. We found a modulated expression of
several genes involved in immune response: Defensin beta 1
(DEFB1), interferon gamma receptor 1, the q subcomponent
of the receptor of complement component 1, stress-
associated endoplasmatic reticulum protein 1 and tyrosyl-
protein sulfotransferase were strongly upregulated. The
expression of C-associated protein of tyrosine phosphatase
(a protein associated with CD45), chemokine (C-C) ligand 5,
the natural killer recognition sequence, colony stimulating
factor 1 and calcium modulating ligand was diminished.
Transport, metabolism, and matrix turnover. Not surpris-
ingly several genes responsible for intracellular transport and
amino-acid/protein metabolism were activated in proteinuric
patients as were genes involved in degradation of proteins
(ubiquitin-conjugating enzyme E2L 6, ubiquitin-like 4,
ubiquitin-conjugating enzyme E2M, ubiquitin-activating
enzyme E1C, F-box and WD-40 domain protein 4 and F-
box and leucine-rich repeat protein 7).
Expression of nine genes involved in lipid metabolism was
altered in our experiments with a predominant upregulation
in patients. Four of these are known to participate in several
steps of fatty acid degradation, that is, dehydrogenase/
reductase (SDR family) member 3, branched chain acyl-
coenzyme A oxidase 2, palmitoyl acyl-coenzyme A oxidase 1
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Table 1 | Functional characterization of 168 genes differentially regulated between patients and controls utilizing GO-terms
Accession number Gene name Symbol Fold change
Apoptosis
AI347538 BCL2-interacting killer (apoptosis inducing) BIK  2.23
R33840 TIA1 cytotoxic granule-associated RNA binding protein TIA1  2.14
W84733 Tax1 (human T-cell leukemia virus type I) binding protein 1 TAX1BP1  1.91
Cell adhesion
AA774044 Thrombospondin 3 THBS3 + 3.67
N29801 A disintegrin and metalloproteinase domain 22 ADAM22 + 2.41
AI214500 Neural cell adhesion molecule 1 NCAM1  2.89
N50845 Contactin 3 CNTN3  2.59
AA428239 BH-protocadherin PCDH7  2.47
AI361991 CD226 antigen CD226  2.56
AA953560 Fibronectin 1 FN1  2.47
AA088202 Collagen, type XVI, and alpha 1 COL16A1  2.16
AI014487 Cysteine-rich, angiogenic inducer, 61 CYR61  3.66
Cell proliferation/cell-cycle control
AA456321 Insulin-like growth factor 1 (somatomedin C) IGF1 + 2.67
H20742 Cell division cycle 34 CDC34 + 2.73
AI984289 Annexin A13 ANXA13 + 3.47
AI368184 Related RAS viral (r-ras) oncogene homolog RRAS + 1.80
H09721 MAP/microtubule affinity-regulating kinase 3 MARK3 + 2.14
AI024631 Protein phosphatase 1D PPM1D  2.25
AW028938 Protein phosphatase 1B PPM1B  2.88
AA598865 Phosphatidic acid phosphatase type 2A PPAP2A  2.88
Cell differentiation
AI886264 Bone morphogenetic protein 7 (osteogenic protein 1) BMP7 + 4.18
H92070 V-ski sarcoma viral oncogene homolog (avian) SKI  2.23
Immune response
AA946653 Defensin, beta 1 DEFB1 + 7.67
H11482 Interferon gamma receptor 1 IFNGR1 + 2.98
AA150505 Complement component 1, q subcomponent, and receptor 1 C1QR1 + 2.42
AA172210 Stress-associated endoplasmic reticulum protein 1 SERP1 + 2.63
N52474 Tyrosylprotein sulfotransferase 1 TPST1 + 2.97
AA481547 Protein tyrosine phosphatase, receptor type, and C-associated protein PTPRCAP  3.62
AA873792 Chemokine (C-C motif) ligand 5 CCL5  2.47
AI382982 Natural killer-tumor recognition sequence NKTR  2.16
AI242464 Colony stimulating factor 1 (macrophage) CSF1  2.09
R14080 Calcium modulating ligand CAMLG  2.39
Transport (intracellular)
H93459 RAB4A, member RAS oncogene family RAB4A + 7.96
AA155803 RAB43, member RAS oncogene family RAB43 + 2.70
AA169814 Sorting nexin 2 SNX2 + 3.34
AA917609 SEC6-like 1 SEC6L1 + 2.77
R55992 SEC14-like 1 SEC14L1 + 2.85
AA069704 Translocase of outer mitochondrial membrane 7 homolog TOMM7 + 2.58
AA972020 RAB6 interacting protein 2 RAB6IP2  2.72
AI272812 Mitochondrial carrier triple repeat 6 MCART6  2.36
AA284180 EH-domain containing 1 EHD1  1.98
Transport (membrane)
AA155640 Transcobalamin I (vitamin B12 binding protein, R binder family) TCN1 + 3.97
AA626279 Potassium voltage-gated channel, Shal-related subfamily, member 3 KCND3 + 1.97
AI075049 Aquaporin 2 (collecting duct) AQP2 + 6.14
H09087 Aquaporin 4 AQP4 + 2.29
H23170 Solute carrier family 1 (high-affinity aspartate/glutamate transporter), member 6 SLC1A6  1.99
AA166885 Solute carrier family 12, (potassium-chloride transporter) member 5 SLC12A5  2.26
W01500 Transient receptor potential cation channel, subfamily C, member 1 TRPC1  3.65
H69810 Chloride channel 3 CLCN3  2.71
Metabolism (amino acid and protein)
R10382 Serine (or cysteine) proteinase inhibitor, member 5 (=protein C inhibitor) SERPINA5 + 8.05
AW071596 Ubiquitin-conjugating enzyme E2L 6 UBE2L6 + 3.26
N64628 Ubiquitin-like 4 UBL4 + 2.64
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Table 1 | Continued
Accession number Gene name Symbol Fold change
AI971344 Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) UBE2M + 2.42
AI309770 Ubiquitin-activating enzyme E1C (UBA3 homolog, yeast) UBE1C + 1.92
AA463476 F-box and WD-40 domain protein 4 SHFM3 + 3.26
AA630881 F-box and leucine-rich repeat protein 7 FBXL7 + 2.78
R52639 Serine hydroxymethyltransferase 1 (soluble) SHMT1 + 3.17
AA733022 FK506 binding protein 14, 22 kDa FKBP14 + 2.85
AA481353 Branched chain aminotransferase 2, mitochondrial BCAT2 + 2.69
AA676588 Chaperonin containing TCP1, subunit 7 (eta) CCT7 + 2.49
AI923312 Calpain 6 CAPN6 + 2.39
AA664056 Prolyl endopeptidase PREP  2.46
T95267 DnaJ (Hsp40) homolog, subfamily C, member 12 DNAJC12  2.77
H80214 Tissue inhibitor of metalloproteinase 1 TIMP1  5.11
Metabolism (lipid)
AA160106 Acid phosphatase 6, lysophosphatidic ACP6 + 3.00
AA211446 1-acylglycerol-3-phosphate O-acyltransferase 3 AGPAT3 + 3.54
W95082 Hydroxysteroid (11-beta) dehydrogenase 2 HSD11B2 + 3.14
AA171606 Dehydrogenase/reductase (SDR family) member 3 DHRS3 + 3.08
R25823 Acetyl-coenzyme A acetyltransferase 2 (acetoacetyl coenzyme A thiolase) ACAT2 + 2.18
T71713 Acyl-coenzyme A oxidase 2, branched chain ACOX2 + 2.62
T62985 Acyl-coenzyme A oxidase 1, palmitoyl ACOX1  2.60
H95792 Acyl-coenzyme A dehydrogenase, short/branched chain ACADSB  2.49
AA481034 Copine 1 CPNE1  2.43
Metabolism (carbohydrate)
AA157261 Phosphatidylinositol glycan, class Q PIGQ + 3.41
AA609458 ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 SIAT2 + 3.34
AW087924 Aldolase A, fructose-bisphosphate ALDOA + 2.57
AW002307 Malic enzyme 1, NADP(+)-dependent, cytosolic ME1  3.31
AI652382 TDP-glucose 4,6-dehydratase TGDS  2.37
AI216166 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 B3GALT4  2.31
Metabolism (nucleic acids)
AI961991 Poly(A)-specific ribonuclease (deadenylation nuclease) PARN  2.09
AA598487 Phosphoribosylglycinamide formyltransferase GART  2.26
Metabolism (general)
T39503 Epoxide hydrolase 1, microsomal (xenobiotic) EPHX1 + 3.14
AA401241 E-1 enzyme MASA + 2.88
AA436549 Nitric oxide synthase interacting protein NOSIP + 2.12
AA884967 Nitric oxide synthase 3 (endothelial cell) NOS3  2.16
AA417700 PH domain and leucine-rich repeat protein phosphatase-like KIAA0931  2.41
AI262683 N-acetyltransferase 2 (arylamine N-acetyltransferase) NAT2  2.23
AI081368 Adenylate cyclase 1 (brain) ADCY1  1.65
Signal transduction
R06605 Protein tyrosine phosphatase, non-receptor type 1 PTPN1 + 5.55
N79051 V-ros UR2 sarcoma virus oncogene homolog 1 (avian) ROS1 + 2.83
AA463213 Protein kinase D3 PRKD3 + 2.09
AA171899 Butyrate-induced transcript 1 HSPC121 + 4.56
AW087914 Casein kinase 1, delta CSNK1D + 2.82
AA992441 COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis) COPS6 + 2.76
AI146565 Neuromedin U NMU + 2.27
AW044654 Frequently rearranged in advanced T-cell lymphomas FRAT1 + 1.96
R36143 Glutamate receptor interacting protein 1 GRIP1  3.69
AA461086 Phosphodiesterase 5A, cGMP-specific PDE5A  3.69
T67004 Endothelin 3 EDN3  3.37
R20227 Guanine nucleotide binding protein (G protein) GNAO1  2.99
W65460 Dual specificity phosphatase 5 DUSP5  2.96
H97140 Dual specificity phosphatase 8 DUSP8  2.41
AA699578 Casein kinase 1, alpha 1 CSNK1A1  2.42
AA130874 Protein tyrosine phosphatase, non-receptor type 14 PTPN14  2.31
H63668 Casein kinase 2, alpha prime polypeptide CSNK2A2  2.26
AI267935 RAB26, member RAS oncogene family RAB26  2.06
AA678971 Regulator of G-protein signalling 9 RGS9  1.82
AA496519 Transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) TLE3  1.74
AI274270 Alpha-kinase 1 ALPK1  3.60
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Table 1 | Continued
Accession number Gene name Symbol Fold change
N34513 Doublecortin and CaM kinase-like 1 DCAMKL1  2.59
H51569 CaM kinase-like vesicle-associated MGC8407  2.18
AA670373 Protein phosphatase 1, regulatory (inhibitor) subunit 14C PPP1R14C  1.86
AA481277 Rho guanine nucleotide exchange factor (GEF) 1 ARHGEF1  2.60
Structural
AA083485 Ribosomal protein L19 RPL19 + 5.95
AA774983 Tropomyosin 4 TPM4 + 2.98
AW078724 Tubulin, beta, 2 TUBB2 + 2.97
H23421 Ribosomal protein L7a RPL7A + 2.83
AA486224 Syncoilin, intermediate filament 1 SYNCOILIN + 2.76
AA426081 Ribosomal protein S14 RPS14 + 2.62
T71680 Mitochondrial ribosomal protein L30 MRPL30 + 2.40
AA211796 SMC2 structural maintenance of chromosomes 2-like 1 (yeast) SMC2L1 + 1.95
H93604 Formin binding protein 1 FNBP1  2.45
AI038302 Matrilin 4 MATN4  2.23
AA464952 Gamma tubulin ring complex protein (76p gene) 76P  2.23
AA404360 SMC5 structural maintenance of chromosomes 5-like 1 (yeast) SMC5L1  2.19
Transcription/translation
AA157011 MADP-1 protein MADP-1 + 2.96
AW087156 PWP1 homolog (S. cerevisiae) ‘endonuclein’ PWP1 + 4.35
W31688 Sp3 transcription factor SP3 + 4.28
AA088434 Zinc-finger protein 3 (A8-51) ZNF3 + 3.99
AA620571 Small nuclear RNA activating complex, polypeptide 3, 50 kDa SNAPC3 + 3.59
AW087153 Mortality factor 4 like 2 MORF4L2 + 3.39
T62072 YEATS domain containing 4 YEATS4 + 2.66
AA485991 Transcription factor CP2 TFCP2 + 2.57
AA025648 Hairless homolog (mouse) HR + 2.56
AA419164 Retinoic acid receptor, beta RARB + 2.46
R56552 Forkhead box K2 FOXK2 + 2.44
N47961 GLIS family zinc finger 1 GLIS1 + 2.39
AA478656 General transcription factor IIF, polypeptide 2, 30 kDa GTF2F2  3.82
AA928017 POU domain, class 2, associating factor 1 POU2AF1  3.06
AA446027 Early growth response 2 (Krox-20 homolog, Drosophila) EGR2  2.80
AI218732 Nuclear receptor subfamily 2, group C, member 2 NR2C2  2.57
R10443 Zinc-finger protein, subfamily 1A, 5 ZNFN1A5  2.53
H97146 ELK3, ETS-domain protein (SRF accessory protein 2) ELK3  2.53
AA206370 RNA binding motif protein 15 RBM15  2.38
N49703 Chromodomain helicase DNA binding protein 2 CHD2  2.30
H38771 Myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila) MLL5  2.27
AA484950 Vitamin D (1,25- dihydroxyvitamin D3) receptor VDR  2.18
AI214272 Forkhead box J3 FOXJ3  2.13
N72495 Zinc-finger homeodomain 4 ZFHX4  2.01
N66572 Spleen focus forming virus (SFFV) proviral integration oncogene spi1 SPI1  1.76
AA482389 Zinc-finger protein 292 ZNF292  1.59
AI368766 Eukaryotic translation elongation factor 1 alpha 2 EEF1A2  2.33
AA233901 KIAA0863 protein KIAA0863  2.25
Hemostasis
T67549 Plasminogen-like B1 PLGL + 6.81
N98524 Coagulation factor X F10  2.26
Hormone binding
T69271 Sex hormone-binding globulin SHBG + 3.84
Nucleus
H15111 Uracil-DNA glycosylase UNG + 4.70
T59256 Prickle-like 2 (Drosophila) PRICKLE2 + 3.07
AA953294 Sjogren’s syndrome nuclear autoantigen 1 SSNA1 + 2.72
AI888464 Cleavage stimulation factor, 3’ pre-RNA, subunit 1, 50 kDa CSTF1 + 2.37
AA398090 Nucleoporin like 2 NUPL2  3.20
AA417948 TRNA selenocysteine-associated protein SECP43  2.44
Membrane
W47484 Opioid receptor, sigma 1 OPRS1 + 3.53
AA126879 Mal, T-cell differentiation protein 2 MAL2 + 2.93
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and short/branched chain acyl-coenzyme A dehydrogenase.
We also found a strong upregulation of the expression of
hydroxysteroid (11-beta) dehydrogenase 2, an enzyme that
catalyzes the conversion of cortisol to the inactive metabolite
cortisone.
We found differentially regulated expression of proteinase-
inhibitors: although the expression of serine proteinase inhibitor
5 was markedly increased, the expression of tissue inhibitor
of metalloproteinase 1 (collagenase 1; TIMP1) was reduced.
Serine proteinase inhibitor 5, also known as protein C
inhibitor or plasminogen activator inhibitor 3 is synthesized
and localized in kidney tissue where it provides unspecific
protease inhibitory activity.20 Interestingly, in vitro experi-
ments with plasminogen activator inhibitor 1 and plasmino-
gen activator inhibitor 3 in breast cancer cell lines suggest a
downstream effect of these proteins on the expression of cell
adhesion molecules of the integrin family.21
TIMP1 modulates extra-cellular matrix turnover by
inhibition of several members of the metalloproteinase
family. Just recently it was shown that hepatocyte growth
factor – known for its antifibrotic effects – reduced the
expression of TGF-b1, collagen IV alpha 2, TIMP-1, and
increased metalloproteinase-2 levels in glomerular cells of
donor kidney biopsies22 suggesting an interesting multiway
relationship between hepatocyte growth factor, TGF-b1,
TIMP-1 and metalloproteinases.
In addition to changes in carbohydrate and nucleic acid
metabolism alterations in two other metabolic transcripts
seem worth mentioning: nitric oxide synthase interacting
protein and nitric oxide synthase 3 (NOS3¼ eNOS; i.e.
endothelial isoform of NOS). Proteinuria caused a strong
upregulation of nitric oxide synthase interacting protein and
a reduced expression of NOS3. Recently, eNOS has been
identified as the NOS isoform responsible for NO production
and regulation of NaCl absorption by the thick ascending
loop of Henle.23 This effect seems to be regulated by luminal
flow. However, the role of eNOS in the proximal tubule cell is
more controversial and still not elucidated.24 Interestingly,
nitric oxide synthase interacting protein has been proposed as
a modulator of eNOS activity, but its expression in renal
tubule cells has not been described yet.25
Signal transduction. We found differential expression of
several transcripts involved in the Wnt-signalling pathway
(casein kinase 1: delta and alpha 1, FRAT1, alpha prime
polypeptide of casein kinase 2 and TLE3). Furthermore the
expression of non-receptor type 1 protein tyrosine phospha-
tase (PTPase, PTPN1), which has been shown to be a
negative regulator of insulin- and IGF-1-stimulated signal-
ling, was increased. On the other hand the expression of
another PTPase, the non-receptor type 14 PTPase, was
reduced. Two members of the dual specificity phosphatase
superfamily dual specificity phosphatase 5 (DUSP5) and
DUSP8 showed a decreased expression. These phosphatases
negatively regulate members of the MAP kinase superfamily,
which are associated with cellular proliferation and differ-
entiation. DUSP5 has a substrate specificity towards the
extracellular signal-regulated kinase (ERK) family of MAP
kinases, whereas DUSP8 predominantly inactivates stress-
activated protein kinase/c-Jun N-terminal kinase and p38.
Transcription factors. Among all the genes differentially
expressed between patients and controls we found 12
transcription factors up- and 16 downregulated in the patient
group. Five of the 12 upregulated transcription factors have
previously been implicated in the regulation of growth, cell
proliferation and cell differentiation (PWP1, ZNF3, mortality
factor 4-like protein 2, YEATS4 and RARB). Both mortality
factor 4-like protein 2 and YEATS4 encode components of
the nua4 histone acetyltransferase complex which is involved
in the activation of transcriptional programs associated with
oncogene growth-induction, tumor suppressor mediated
growth arrest and replicative senescence, apoptosis and
DNA repair. In the group of downregulated transcription
factors we found – among others – decreased expression of
early growth response-2 and ELK3 transcription factors.
Early growth response family members (in particular early
growth response-2 and early growth response-3) regulate
nonlymphoid expression of Fas ligand, tumor necrosis
factor-related apoptosis-inducing ligand, and tumor necrosis
factor during immune response and may induce apoptosis of
T cells.26 ELK-3 is a member of the ternary complex factors
subfamily of Ets proteins, along with ELK-1 and Sap-1, which
are involved in transcriptional regulation of genes important
for determining tissue specificity, cellular differentiation, and
cellular proliferation.
Real-time PCR analysis of selected genes
We selected five genes from five different functional groups
for validation experiments by Taqman real-time polymerase
chain reaction (PCR) analysis, namely DEFB1, TIMP1,
DUSP5, BMP7, and RAB4A. We used glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as the endogenous
control. A high correlation between array and real-time
Table 1 | Continued
Accession number Gene name Symbol Fold change
N26125 Neuropilin 2 NRP2  2.51
R71781 EPS8-like 1 EPS8L1  2.23
AA047567 Progesterone receptor membrane component 2 PGRMC2  2.18
AA453486 Signal sequence receptor, gamma (translocon-associated protein gamma) SSR3  2.43
Numbers are fold changes. (+) indicates upregulation in patients, whereas () indicates suppressed sequences.
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PCR results was observed for all five genes (Figure 1). In
particular, there were no directional changes, and the Pearson
correlation between array and PCR was 0.79–0.81.
Immunohistochemical localization of TSP-3 and BMP-7 in
kidney biopsies
We selected two proteins from two functional groups to
underscore our gene expression results: TSP-3 (cell adhesion)
and BMP-7 (cell differentiation). Conventional immunohis-
tochemistry showed a low expression of TSP-3 in nearly all
tubules in control samples (Figure 2a) and a significant
increase of expression in patients (Figure 2b). The immuno-
histochemical staining showed no BMP-7 expression in
control subjects except in distal tubules (Figure 3a). However,
in proteinuric patients we saw a strong expression of this
protein in nearly all tubules (Figure 3b). Interestingly, we
found the strongest immunohistochemical signal of BMP-7
protein at the luminal side of tubular epithelial cells. Neither
of those proteins was detected in the glomeruli.
DISCUSSION
In this study we combined two innovative, novel and potent
technologies: We isolated specifically RPTEC from patients
and controls using laser capture microdissection, and we
performed transcriptome analysis using cDNA microarray
technology. This approach has several striking advantages:
(a) our results can clearly be attributed to RPTEC, which
have been shown to be a key player in the pathogenesis of
progressive renal disease. (b) Genome-wide gene expression
analysis and bioinformatic workup is the only way to identify
regulatory networks affected by proteinuria overcoming
many shortfalls of ‘single-gene’ approaches. (c) Using human
biopsies the problems of interpretation of animal and/or cell
culture can be avoided.
Supervised analysis showed significant transcriptional
differences in genes, which play a major role in cell adhesion,
cell proliferation, cell cycle control, cell differentiation, and in
lipid-, amino-acid-, and protein-metabolism as well as in the
groups of intracellular- and membrane-transport protein
coding genes.
The differential regulation of genes involved in intracel-
lular transport, amino-acid-, and protein- as well as lipid-
metabolism reflects enhanced reabsorption and degradation
of proteins via ubiquitination in the state of proteinuria. It
has been demonstrated in vitro in opossum kidney cells27 and
in human proximal tubular cells17 as well as in vivo in a
murine animal model18 that proteinuria – notably albumi-
nuria – is linked with proliferation of tubular cells. Dixon and
Brunskill27 showed that albumin-induced stimulation of
growth and proliferation of proximal tubular cells is
dependent on the ERK family of MAP kinases, whose activity
is also likely to be increased in our patients owing to the
reduced activity of DUSP5 and DUSP8. The findings of
Takaya et al.28 suggest an involvement of the ERK pathway in
BSA-induced monocyte chemoattractant protein-1 expres-
sion in mouse proximal tubular cells, and the authors suggest
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Figure 1 | Taqman real-time PCR analysis of five selected genes
from Table 1. DEFB1 (Hs.32949), TIMP1 (Hs.522632), DUSP5
(Hs.2128), BMP7 (Hs.473163) and RAB4A (member of the ras
oncogene family, Hs.296169). All numbers represent log-transformed
fold-change values between patients and controls where positive
values indicate higher expression in patients. The real-time PCR
results were calculated as relative expression to the internal standard
glyceraldehyde-3-phosphate dehydrogenase using the delta–delta-ct
method. Real-time experiments showed a Pearson’s correlation of
0.81 when compared to Microarray results of the seven selected
patients, and 0.79 when compared to expression values from all
patients, respectively (see Materials and Methods section).
a b
Figure 2 | Immunohistochemical staining of TSP-3.
(a, b) Immunostaining for TSP-3: original magnification  40. (a) In
control subjects we found a weak TSP-3 signal in all tubule cells.
(b) In proteinuric patients a strong positive staining for TSP-3 was
observed in most of the tubule cells.
a b
Figure 3 | Immunohistochemical staining of BMP-7.
(a, b) Immunostaining for BMP-7: original magnification  20. (a) In
healthy subjects we did not detect any positive BMP-7 signal in
proximal tubules and neither in the glomeruli. Arrows: there are single
distal tubules with a weak BMP-7 staining. (b) Stable proteinuric
patients showed a strong BMP-7 staining in tubule cells. Interestingly,
we found the most prominent staining at the luminal side of the cells.
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as well a possible interaction of nuclear factor-kappaB with
ERK. Accordingly, we observed a significant transcriptional
change in the functional category of immune response genes.
We also found an elevated expression of IGF-1 in proteinuric
patients. IGF-1 has been studied extensively in the context of
hypertrophic renal growth associated with common renal
diseases like diabetic nephropathy. In murine tubular
epithelial cells IGF-1 stimulates the activities of the MAP
kinases ERK1/ERK2.29 These findings strongly indicate a
proliferative state in human RPTEC exposed to proteinuria,
at least at an early stage of disease.
The role of apoptosis of tubular cells in the pathogenesis
of progressive renal disease is still discussed controversially.30
On the one hand it was shown in numerous studies that
albumin induces apoptosis of proximal tubule cells,31,32 on
the other hand Iglesias et al.33 showed that albumin is a
major survival factor for tubule cells through scavenging of
reactive oxygen species. Considering the simultaneous
decreased expression of pro- and antiapoptotic stimuli and
the lack of significant transcriptional alterations of well-
characterized apoptosis-related genes, we cannot draw a
definitive conclusion with respect to the impact of pro-
grammed cell death at this stage of disease.
Our analysis identified a significant downregulation of
genes involved in cell adhesion in RPTEC from patients,
compatible with the induction of EMT. An emerging body of
evidence suggests numerous signalling pathways as initiators
of EMT of proximal tubular cells, the final common hallmark
being a decrease in E-cadherin expression, resulting in
reduced cell–cell interaction and diminished adhesion of
tubule cells to the basolateral membrane.10 EMT is an
important process which enables tubular epithelial cells to
acquire a mesenchymal phenotype, migrate from the tubular
lumen into the interstitium and escape apoptosis. TGF-b1
has been described as one of the main inducers of EMT.
However, EMT would ultimately lead to a loss of organ
function and therefore counter-regulatory pathways are
present. It has been suggested that finally an imbalance
between pro- and antifibrotic growth factors/hormones
determines the fate of the kidney.34,35 In our patients renal
function was well maintained and tubulointerstitial fibrosis
was minimal despite a mean duration of the disease of 7
months before biopsy. Furthermore, serum creatinine values
were stable during a follow-up period of 2 years. However,
one has to acknowledge that some patients received
immunosuppressive therapy after the biopsy. Nonetheless,
at least at the time of biopsy protective mechanisms might
sufficiently counteract the above-described deleterious ef-
fects. One of the endogenous antagonists of TGF-b1 with
respect to EMT is bone morphogenic protein-7 (BMP-7).
BMP-7 expression was significantly elevated in our patient
samples, and we confirmed the results as well on the protein
level. Our findings are compatible with the data obtained by
Zeisberg et al.11 who showed in vitro that chronic renal injury
induced by TGF-b1 can be counteracted and even reversed by
the application of BMP-7, suggesting an association of those
two molecules within the intracellular pathways. In many
animal models of chronic kidney injury these results were
confirmed unequivocally showing that administration of
BMP-7 has positive therapeutic effects in terms of reduced
injury, accelerated regeneration, inhibition of tubular atro-
phy, inhibition of interstitial fibrosis, and even improvement
of glomerular filtration rate.11,36–40
In addition, the differential regulation of genes involved in
Wnt signalling is in line with the idea of simultaneous
presence of proteinuria associated injury and repair mechan-
isms. Just recently, the Wnt signalling system has been
implicated as a new potential mediator of mesenchymal-to-
epithelial transition in murine models of acute renal failure41
and unilateral urethral obstruction.42 The key factor of Wnt
signalling is b-catenin. The intracellular-concentration of
b-catenin, which is regulated by degradation of b-catenin by
paired phosphorylation through the serine/threonine kinases
casein kinase I and glycogen synthase-3b is the rate
determining factor of the Wnt-signalling cascade. Interest-
ingly, recent studies showed several connections between
Wnt- and b-catenin signalling and cadherin-mediated cell
adhesion, in which also the key event is b-catenin stability
and availability.43 In our experiments we found a differential
expression of three isoforms of casein kinase 1: delta
(upregulated), alpha 1, and alpha prime polypeptide (down-
regulated). Furthermore, we found two PTPases to be as well
differentially regulated between patients and controls: PTPN1
(up) and PTPN14 (down). Activation of PTPases has been
implicated in the stabilization of the cadherin–catenin
complex resulting in increased cadherin-mediated cell–cell
adhesion.44 Although we did not find a differential expression
of the main members of the Wnt-gene family (e.g. Wnt-4),
the significant accumulation of these kinases and phospha-
tases suggests a well-balanced regulation of the cadherin–ca-
tenin complex in human RPTEC exposed to proteinuria.
Our study has several limitations, the major probably
being the limited number of samples being included. As we
used a very stringent statistical analysis it is likely that this
fact might have precluded the identification of additional,
potentially at least as important genetic alterations. Further-
more, we monitored changes in transcriptional profiles, and
it is unclear if indeed identical profiles would be obtained on
a protein level, despite encouraging immunostaining results
for two of these genes. This might especially hold true for
several well known key mediators in the pathogenesis of renal
fibrosis, for example, TGF-b1, monocyte chemoattractant
protein-1, ET-1, regulated upon activation normal T-cell
expressed and secreted, platelet-derived growth factor-AB,
and interleukin-8 as well as nuclear factor NF-kappaB and
others, where we did not see any significant difference in gene
expression between patients and controls. However, it has to
be emphasized that these patients were diagnosed at a very
early stage of kidney disease, that is, they had a short
duration of disease before biopsy (mean: 7 months), a near-
to-normal serum creatinine and a low level of tubulointer-
stitial fibrosis (mediano10%). Another point potentially
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having an impact on the results of this study is the age
difference between patients and controls. It has been
suggested recently that tissue specific gene expression may
alter with age.45 Finally, the biopsy provides information on
only a specific time point. As renal function was close to
normal we cannot draw a conclusion about the changes,
which have to occur to alter the balance in favor of disease
progression.
Nonetheless, our results underscore the importance of
using a genome-wide approach to dissect complex patho-
physiological responses during a disease process as focusing
on specific pathogenetic pathways does not allow taking into
account endogenous counter-regulatory networks. Our study
shows that the latter are able at least in some patients to lead
to a clinically stable condition. New therapeutic interventions
should therefore not only focus on the blockade of
deleterious pathways but also might be successful if they
increase the self-repair potential.
MATERIALS AND METHODS
Patient characteristics
We used surplus biopsy material stored at 801C from 19 patients
with proteinuria for this study: focal-segmental glomerulosclerosis,
n¼ 6; minimal-change disease n¼ 5; immunoglobulin A nephro-
pathy n¼ 8. Biopsies from the unaffected part of kidneys removed
because of renal cell carcinoma were used as controls (n¼ 5).
Light microscopy was performed using hematoxylin/eosin and
periodic-acid-Schiff or Pearse-stained sections. A semiquantitative
scoring of tubulointerstitial fibrosis was performed by an indepen-
dent pathologist. Clinical data of patients and controls are shown
in Table 2. As renal cell carcinoma is more a disease of the elderly,
age was significantly different between patients and controls as was
proteinuria. Serum creatinine was normal in the control group and
only slightly but not significantly higher in the patient group.
The median degree of tubulointerstitial fibrosis was o10%. The
study was approved by the institutional review board of the Medical
University of Innsbruck.
Isolation of tubule cells from biopsies
After alkaline phosphatase (4-Nitro Blue Tetrazolium Chloride/5-
Bromo-4-chloro-3-indolyl phosphate) staining under RNase-free
conditions proximal tubular epithelial cells were identified and isolated
using the PixCell IIs Laser Capture Microdissection System and
CapSureTM LCM Caps (Arcturus, Mountain View, CA, USA; Figure 4).
Neither the staining nor the LCM procedure affected the quality of the
RNA as assessed by agarose gel-electrophoresis and semiquantitative
reverse transcription-PCR of beta-actin (data not shown).
RNA isolation, quality control, and linear amplification
Total RNA was isolated using the Pico PureTM RNA Isolation Kit
(Arcturus, Mountain View, CA, USA). A semiquantitative reverse
transcription-PCR of beta-2-microglobulin was carried out and only
samples with a positive signal were studied further. Owing to
approximately 1 ng of RNA per sample we performed two rounds of
linear RNA amplification using the RiboAmpTM RNA Amplification Kit
(Arcturus, Mountain View, CA, USA). The reproducibility and
reliability of T7-based linear amplification in the setting of Cy5/Cy3-
cDNA microarrays was shown by our group previously.46 Amplified
Universal Human Reference RNA (Stratagene, La Jolla, CA, USA) served
as reference material. The quality of the amplified RNA was assessed by
spectrophotometry (A260/280), on an ethidium bromide stained 1.5%
agarose gel and with the Agilent Bioanalyzer and RNA6000 LabChipTM
Kit (Agilent, Palo Alto, CA, USA). After two rounds of amplification
the length of the amplified RNA was 133–1025 bp (Table S4).
Labelling and microarray hybridization
Using the CyScribe cDNA Post-Labelling Kit (Amersham Bios-
ciences, GE Healthcare, UK) 1 mg of amplified sample RNA (Cy5,
red) and the reference RNA (Cy3 green) were labelled as described
previously.46 cDNA microarrays were obtained from Stanford
Functional Genomics Facility (www.microarray.org/sfgf/). They
contained 41 792 spots representing 30325 genes assigned to a
UniGene cluster and 11 467 ESTs. All samples were processed in
technical duplicates. Arrays were scanned using a GenePix 4000B
microarray scanner and the images were analyzed with the GenePix
Pro 4.0 software (Axon Instruments, Union City, CA, USA). The raw
data as well as array images were transferred to the Stanford
Table 2 | Characteristics of patients and controls
Clinical Controls Patients Pa
Age (years) 67.678.0 40.8716.0 0.0062
Female/male 2/3 6/13 0.2578
SCrea (mg/dl) 1.0970.10 1.3770.89 1.0000
UProt (g/d) Neg
a 6.879.7
Histology
Degree of tubular atrophy and interstitial fibrosisb Number of patients
0 2
1 8
2 2
3 4
4 and 5 0
Median 1 (i.e. o10%)
aP-value was calculated using Mann–Whitney U-test (SCrea, age) and two-way-ANOVA (sex). Absence of proteinuria in healthy control subjects was defined as a negative urine
dipstick.
bThe degree of tubulointerstitial fibrosis was examined on PAS- or Pearse-stained material: 0=no fibrosis, 1=o10%, 2=10 to 25%, 3=25 to 50%, 4=50 to 75% and 5=475%.
SCrea serum creatinin, Uprot urinary protein excretion.
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Microarray Database for data storage and advanced data analysis
(http://genome-www5.stanford.edu/MicroArray/SMD). All experi-
ments were performed according to the minimum information
about a microarray experiment microarray guidelines.47
Validation of microarray results by real-time PCR
Only approximately 1 ng of total RNA could be isolated from each
frozen section. Enough frozen sections were available from seven
patient samples included in the analysis (three focal segmental
glomerular sclerosis, three immunoglobulin A nephropathy, and one
minimal change disease) and from all five controls to allow another
RPTEC isolation procedure, and the RNA obtained was pooled.
Equal amounts of total RNA isolated from patient biopsies and from
control samples were reverse transcribed (Sensiscript RT Kit,
Qiagen, Hilden, Germany) according to the manufacturers protocol
and used for real-time PCR. We used GAPDH as endogenous
control. We selected five genes from five different functional groups
(Figure 1): DEFB1 (immune response), TIMP1 (protein modifica-
tion), DUSP5 (signal transduction), BMP7 (cell differentiation) and
RAB4A (intracellular transport). Real-time experiments were
performed using Assays-on-DemandTM Gene Expression pre-devel-
oped primers and FAMTM labelled TaqManTM probes (www.allgen-
es.com; DEFB1 Hs00174765m1; TIMP1 Hs00171558m1; DUSP5
Hs00244839m1; RAB4A Hs00190157m1; BMP7 Hs00233476m1;
glyceraldehyde-3-phosphate dehydrogenase Hs99999905m1). Quanti-
fication of gene expression was performed on a TaqMan ABI Prism
7700 Sequence Detection SystemTM using the manufacturer´s software
(both Applied Biosystems, Foster City, CA, USA).
Data processing, statistical analysis, and functional annota-
tion
After excluding spots with an intensity of o1.2 above background and
applying an 80% filter (i.e. accepting only genes with values in at least
80% of the arrays) 24961 features were left for further analysis. Duplicate
arrays were combined and the values were averaged. Supervised analysis
combined two statistical procedures to identify differentially expressed
genes between patients and controls: significance analysis of microarrays48
as well as an unpaired t-statistic with correction for multiple testing
according to Westfall and Young.49 A false discovery rate of o1% was
allowed in the significance analysis of microarrays method and only genes
showing an adjusted Po0.05 were considered further after t-testing.
The genes were further analyzed with regard to their molecular
functions and biological processes (Tables S2 and S3) using gene ontology
terms from the Gene Ontology Consortium50 provided by the SOURCE
tool from the Stanford Genomics Facility51 and the PANTHER
classification system.52 Biological processes of genes were compared to
the PANTHER reference data set. The ratio of expected to the observed
frequencies of genes assigned to certain ontology categories were
compared by using the w2 test to derive significance of differences.
Additional functional grouping of genes (as used in Table 1) was based on
gene ontology terms and information derived from Pubmed and iHOP.53
Immunohistochemistry
Frozen tissue samples of representative patients and controls were
fixed with cold acetone. For antibody dilutions and sources see
Table 3. The sections were incubated with the primary antibody for
30 min at room temperature (TSP-3) or overnight at 41C (BMP-7).
For visualization of TSP-3 the mouse ABC Staining System (Santa
Cruz Biotechnology, Santa Cruz, CA, USA, www.scbt.com) was used
in combination with diaminobenzidine. BMP-7 was detected by the
Vectastain Elite ABC Kit (Vector Laboratories, Burlingame, CA,
USA, www.vectorlabs.com) and stained with 3-amino-9-ethylcarba-
zole. Both systems use biotin-conjugated secondary antibodies,
avidin and biotinylated horseradish peroxidase and the correspond-
ing chromogen. All sections were counterstained with 3,30-
diaminobenzidine tetrahydrochloride 3-amino-9-ethyl carbazole.
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SUPPLEMENTARY MATERIAL
Table S1. 62 sequences differentially regulated between patients and
controls (open-reading frames, expressed sequence tags and
hypothetical proteins).
Table S2. Enriched PANTHER ontology categories, which are
significantly upregulated in proteinuric patients.
Table S3. Enriched PANTHER ontology categories, which are
significantly downregulated in proteinuric patients.
Table S4. Length of amplified RNA as analyzed on Agilent
BioanalyzerTM.
Figure 4 | Staining for alkaline phosphatase to identify
proximal tubule cells. Original magnification  40: after staining
for alkaline phosphatase using 4-nitro blue tetrazolium chloride/
5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP), the proximal
tubule cells were identified by showing a strong dark blue staining.
Table 3 | Primary antibodies used for immunohistochemistry
Antigen Species Dilution Source
BMP-7 (N-19) Goat polyclonal 1:50 Santa Cruz Biotechnologies (www.scbt.com)
TSP-3 (A-12) Mouse monoclonal 1:500 Santa Cruz Biotechnologies (www.scbt.com)
BMP, bone morphogenetic protein; TSP, thrombospondin.
334 Kidney International (2007) 71, 325–335
o r i g i n a l a r t i c l e M Rudnicki et al.: Gene expression profiles in proteinuric nephropathies
REFERENCES
1. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease
and decreased kidney function in the adult US population: Third National
Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1–12.
2. Garg AX, Mamdani M, Juurlink DN, van WC. Identifying individuals with a
reduced GFR using ambulatory laboratory database surveillance. J Am
Soc Nephrol 2005; 16: 1433–1439.
3. Tang S, Leung JC, Abe K et al. Albumin stimulates interleukin-8 expression
in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003;
111: 515–527.
4. Wang Y, Rangan GK, Tay YC et al. Induction of monocyte chemoattractant
protein-1 by albumin is mediated by nuclear factor kappaB in proximal
tubule cells. J Am Soc Nephrol 1999; 10: 1204–1213.
5. Kitagawa K, Wada T, Furuichi K et al. Blockade of CCR2 ameliorates
progressive fibrosis in kidney. Am J Pathol 2004; 165: 237–246.
6. Zoja C, Morigi M, Figliuzzi M et al. Proximal tubular cell synthesis and
secretion of endothelin-1 on challenge with albumin and other proteins.
Am J Kidney Dis 1995; 26: 934–941.
7. Zoja C, Donadelli R, Colleoni S et al. Protein overload stimulates RANTES
production by proximal tubular cells depending on NF-kappa B
activation. Kidney Int 1998; 53: 1608–1615.
8. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ. Regulation of
endothelin-1 and transforming growth factor-beta1 production in
cultured proximal tubular cells by albumin and heparan sulphate
glycosaminoglycans. Nephrol Dial Transplant 2001; 16: 1769–1775.
9. Oldroyd SD, Miyamoto Y, Moir A et al. An IGF-I antagonist does not inhibit
renal fibrosis in the rat following subtotal nephrectomy. Am J Physiol
Renal Physiol 2006; 290: F695–F702.
10. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in
renal fibrosis. J Mol Med 2004; 82: 175–181.
11. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts
TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
chronic renal injury. Nat Med 2003; 9: 964–968.
12. Gollub J, Ball CA, Binkley G et al. The Stanford Microarray Database: data
access and quality assessment tools. Nucleic Acids Res 2003; 31: 94–96.
13. Qabar A, Derick L, Lawler J, Dixit V. Thrombospondin 3 is a pentameric
molecule held together by interchain disulfide linkage involving two
cysteine residues. J Biol Chem 1995; 270: 12725–12729.
14. Ziehr J, Sheibani N, Sorenson CM. Alterations in cell-adhesive and
migratory properties of proximal tubule and collecting duct cells from
bcl-2 / mice. Am J Physiol Renal Physiol 2004; 287: F1154–F1163.
15. Yang J, Zhang X, Li Y, Liu Y. Downregulation of Smad transcriptional
corepressors SnoN and Ski in the fibrotic kidney: an amplification
mechanism for TGF-beta1 signaling. J Am Soc Nephrol 2003; 14:
3167–3177.
16. Todorovicc V, Chen CC, Hay N, Lau LF. The matrix protein CCN1 (CYR61)
induces apoptosis in fibroblasts. J Cell Biol 2005; 171: 559–568.
17. Ashman N, Harwood SM, Kieswich J et al. Albumin stimulates cell growth,
l-arginine transport, and metabolism to polyamines in human proximal
tubular cells. Kidney Int 2005; 67: 1878–1889.
18. Dixon R, Brunskill NJ. Activation of mitogenic pathways by albumin in
kidney proximal tubule epithelial cells: implications for the pathophysiology
of proteinuric states. J Am Soc Nephrol 1999; 10: 1487–1497.
19. Erkan E, Devarajan P, Schwartz GJ. Apoptotic response to albumin overload:
proximal vs. distal/collecting tubule cells. Am J Nephrol 2005; 25: 121–131.
20. Radtke KP, Fernandez JA, Greengard JS et al. Protein C inhibitor is expressed
in tubular cells of human kidney. J Clin Invest 1994; 94: 2117–2124.
21. Palmieri D, Lee JW, Juliano RL, Church FC. Plasminogen activator
inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435
breast cancer cells. J Biol Chem 2002; 277: 40950–40957.
22. Esposito C, Parrilla B, De MA et al. Hepatocyte growth factor (HGF) modulates
matrix turnover in human glomeruli. Kidney Int 2005; 67: 2143–2150.
23. Ortiz PA, Hong NJ, Garvin JL. Luminal flow induces eNOS activation and
translocation in the rat thick ascending limb. Am J Physiol Renal Physiol
2004; 287: F274–F280.
24. Wang T. Role of iNOS and eNOS in modulating proximal tubule transport
and acid–base balance. Am J Physiol Renal Physiol 2002; 283: F658–F662.
25. Dedio J, Konig P, Wohlfart P et al. NOSIP, a novel modulator of
endothelial nitric oxide synthase activity. FASEB J 2001; 15: 79–89.
26. Droin NM, Pinkoski MJ, Dejardin E, Green DR. Egr family members
regulate nonlymphoid expression of Fas ligand TRAIL, and tumor necrosis
factor during immune responses. Mol Cell Biol 2003; 23: 7638–7647.
27. Dixon R, Brunskill NJ. Albumin stimulates p44/p42 extracellular-signal-
regulated mitogen-activated protein kinase in opossum kidney proximal
tubular cells. Clin Sci (London) 2000; 98: 295–301.
28. Takaya K, Koya D, Isono M et al. Involvement of ERK pathway in
albumin-induced MCP-1 expression in mouse proximal tubular cells.
Am J Physiol Renal Physiol 2003; 284: F1037–F1045.
29. Senthil D, Choudhury GG, Abboud HE et al. Regulation of protein
synthesis by IGF-I in proximal tubular epithelial cells. Am J Physiol Renal
Physiol 2002; 283: F1226–F1236.
30. Iglesias J, Levine JS. Albuminuria and renal injury – beware of proteins
bearing gifts. Nephrol Dial Transplant 2001; 16: 215–218.
31. Arici M, Chana R, Lewington A et al. Stimulation of proximal tubular cell
apoptosis by albumin-bound fatty acids mediated by peroxisome
proliferator activated receptor-gamma. J Am Soc Nephrol 2003; 14: 17–27.
32. Erkan E, Garcia CD, Patterson LT et al. Induction of renal tubular cell
apoptosis in focal segmental glomerulosclerosis: roles of proteinuria and
Fas-dependent pathways. J Am Soc Nephrol 2005; 16: 398–407.
33. Iglesias J, Abernethy VE, Wang Z et al. Albumin is a major serum survival
factor for renal tubular cells and macrophages through scavenging of
ROS. Am J Physiol 1999; 277: F711–F722.
34. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis.
N Engl J Med 1994; 331: 1286–1292.
35. Sporn MB. The importance of context in cytokine action. Kidney Int 1997;
51: 1352–1354.
36. Hruska KA, Guo G, Wozniak M et al. Osteogenic protein-1 prevents renal
fibrogenesis associated with ureteral obstruction. Am J Physiol Renal
Physiol 2000; 279: F130–F143.
37. Vukicevic S, Basic V, Rogic D et al. Osteogenic protein-1 (bone
morphogenetic protein-7) reduces severity of injury after ischemic acute
renal failure in rat. J Clin Invest 1998; 102: 202–214.
38. Wang S, Chen Q, Simon TC et al. Bone morphogenic protein-7 (BMP-7), a
novel therapy for diabetic nephropathy. Kidney Int 2003; 63: 2037–2049.
39. Zeisberg M, Bottiglio C, Kumar N et al. Bone morphogenic protein-7
inhibits progression of chronic renal fibrosis associated with two genetic
mouse models. Am J Physiol Renal Physiol 2003; 285: F1060–F1067.
40. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces
mesenchymal to epithelial transition in adult renal fibroblasts and facilitates
regeneration of injured kidney. J Biol Chem 2005; 280: 8094–8100.
41. Terada Y, Tanaka H, Okado T et al. Expression and function of the
developmental gene Wnt-4 during experimental acute renal failure in
rats. J Am Soc Nephrol 2003; 14: 1223–1233.
42. Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling
is activated after unilateral ureteral obstruction, and recombinant
secreted frizzled-related protein 4 alters the progression of renal fibrosis.
J Am Soc Nephrol 2005; 16: 2373–2384.
43. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin
pathways. Science 2004; 303: 1483–1487.
44. Hellberg CB, Burden-Gulley SM, Pietz GE, Brady-Kalnay SM. Expression of
the receptor protein-tyrosine phosphatase PTPmu, restores E-cadherin-
dependent adhesion in human prostate carcinoma cells. J Biol Chem
2002; 277: 11165–11173.
45. Melk A, Mansfield ES, Hsieh SC et al. Transcriptional analysis of the
molecular basis of human kidney aging using cDNA microarray profiling.
Kidney Int 2005; 68: 2667–2679.
46. Rudnicki M, Eder S, Schratzberger G et al. Reliability of t7-based mRNA
linear amplification validated by gene expression analysis of human
kidney cells using cDNA microarrays. Nephron Exp Nephrol 2004; 97:
e86–e95.
47. Brazma A, Hingamp P, Quackenbush J et al. Minimum information about
a microarray experiment (MIAME)-toward standards for microarray data.
Nat Genet 2001; 29: 365–371.
48. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;
98: 5116–5121.
49. Westfall PH, Young SS. Resampling-based Multiple Testing: Examples and
Methods for P-Value Adjustment. Wiley Series in Probability and
Mathematical Statistics. Wiley: New York, 1993.
50. Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the
unification of biology. The Gene Ontology Consortium. Nat Genet 2000;
25: 25–29.
51. Diehn M, Sherlock G, Binkley G et al. SOURCE: a unified genomic resource
of functional annotations, ontologies, and gene expression data. Nucleic
Acids Res 2003; 31: 219–223.
52. Thomas PD, Kejariwal A, Campbell MJ et al. PANTHER: a browsable
database of gene products organized by biological function, using
curated protein family and subfamily classification. Nucleic Acids Res 2003;
31: 334–341.
53. Hoffmann R, Valencia A. A gene network for navigating the literature. Nat
Genet 2004; 36: 664.
Kidney International (2007) 71, 325–335 335
M Rudnicki et al.: Gene expression profiles in proteinuric nephropathies o r i g i n a l a r t i c l e
